diabetes care

ABBOTT PARK, Ill., August 25, 2026 Abbott announced that the U.S. Food and Drug Administration (FDA) has authorized Libre...

Plainsboro, New Jersey, August,11, 2026 Novo Nordisk has announced the nationwide U.S. launch of Awiqli® (insulin icodec-abae) injection 700...

PLAINSBORO, N.J. and BAGSVÆRD, Denmark, June 6, 2026 Novo Nordisk has announced positive results from a Phase 2 clinical...

MUMBAI, India and NAPLES, Fla., May 18, 2026 Lupin Limited has announced that it has received tentative approval from...

BASEL, Switzerland, May 15, 2026 Sandoz has announced that the European Commission (EC) granted marketing authorization for two biosimilar...

VANCOUVER, BC — December 5, 2025 — TempraMed Technologies Ltd. announced a major expansion into Western Europe through a...